UK markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,392.40+12.40 (+0.90%)
At close: 05:59PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) 56.13B
Enterprise value 71.08B
Trailing P/E 12.62
Forward P/E 9.24
PEG ratio (5-yr expected) 1.06
Price/sales (ttm)1.46
Price/book (mrq)6.13
Enterprise value/revenue 1.85
Enterprise value/EBITDA 7.25

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-9.36%
S&P500 52-week change 3-13.51%
52-week high 32,746.59
52-week low 31,280.92
50-day moving average 31,365.26
200-day moving average 31,580.44

Share statistics

Avg vol (3-month) 39.4M
Avg vol (10-day) 36.83M
Shares outstanding 54.07B
Implied shares outstanding 6N/A
Float 83.92B
% held by insiders 10.71%
% held by institutions 143.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 45.48%
Trailing annual dividend rate 30.76
Trailing annual dividend yield 30.06%
5-year average dividend yield 45.34
Payout ratio 478.88%
Dividend date 3N/A
Ex-dividend date 417 Nov 2022
Last split factor 24:5
Last split date 319 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 35.65%
Operating margin (ttm)24.19%

Management effectiveness

Return on assets (ttm)8.36%
Return on equity (ttm)34.77%

Income statement

Revenue (ttm)38.44B
Revenue per share (ttm)9.56
Quarterly revenue growth (yoy)18.10%
Gross profit (ttm)22.66B
EBITDA 11.72B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)1.09
Quarterly earnings growth (yoy)783.10%

Balance sheet

Total cash (mrq)7.16B
Total cash per share (mrq)1.77
Total debt (mrq)22.12B
Total debt/equity (mrq)253.74
Current ratio (mrq)0.97
Book value per share (mrq)2.27

Cash flow statement

Operating cash flow (ttm)9.27B
Levered free cash flow (ttm)9.04B